Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54,486,781
-
Total 13F shares
-
32,446,135
-
Share change
-
+504,195
-
Total reported value
-
$1,298,005,471
-
Price per share
-
$40.01
-
Number of holders
-
202
-
Value change
-
+$24,674,059
-
Number of buys
-
108
-
Number of sells
-
88
Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q4 2015
As of 31 Dec 2015,
Emergent BioSolutions Inc. - Common Stock (EBS) was held by
202 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,446,135 shares.
The largest 10 holders included
VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, BlackRock Fund Advisors, Bank of New York Mellon Corp, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, STATE STREET CORP, D. E. Shaw & Co., Inc., BlackRock Institutional Trust Company, N.A., and LOOMIS SAYLES & CO L P.
This page lists
202
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.